HEADER COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE) 22-MAR-96 1IRS TITLE IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, TITLE 2 MINIMIZED AVERAGE STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IRS-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PTB DOMAIN; COMPND 5 SYNONYM: INSULIN RECEPTOR SUBSTRATE 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: IL-4 RECEPTOR PHOSPHOPEPTIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL21 (DE2) PLYSS; SOURCE 6 CELL_LINE: BL21; SOURCE 7 ORGAN: SKELETAL; SOURCE 8 GENE: PTB DOMAIN OF IRS-1; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET30B; SOURCE 12 EXPRESSION_SYSTEM_GENE: PTB DOMAIN OF IRS-1; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHOTYROSINE BINDING DOMAIN (PTB), COMPLEX, SIGNAL TRANSDUCTION, KEYWDS 2 COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE), COMPLEX (SIGNAL TRANSDUCTION- KEYWDS 3 PEPTIDE) COMPLEX EXPDTA SOLUTION NMR AUTHOR M.-M.ZHOU,B.HUANG,E.T.OLEJNICZAK,R.P.MEADOWS,S.B.SHUKER,M.MIYAZAKI, AUTHOR 2 T.TRUB,S.E.SHOELSON,S.W.FEISK REVDAT 3 23-FEB-22 1IRS 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1IRS 1 VERSN REVDAT 1 15-MAY-97 1IRS 0 JRNL AUTH M.M.ZHOU,B.HUANG,E.T.OLEJNICZAK,R.P.MEADOWS,S.B.SHUKER, JRNL AUTH 2 M.MIYAZAKI,T.TRUB,S.E.SHOELSON,S.W.FESIK JRNL TITL STRUCTURAL BASIS FOR IL-4 RECEPTOR PHOSPHOPEPTIDE JRNL TITL 2 RECOGNITION BY THE IRS-1 PTB DOMAIN. JRNL REF NAT.STRUCT.BIOL. V. 3 388 1996 JRNL REFN ISSN 1072-8368 JRNL PMID 8599766 JRNL DOI 10.1038/NSB0496-388 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.WOLF,T.TRUB,E.OTTINGER,L.GRONINGA,A.LYNCH,M.F.WHITE, REMARK 1 AUTH 2 M.MIYAZAKI,J.LEE,S.E.SHOELSON REMARK 1 TITL PTB DOMAINS OF IRS-1 AND SHC HAVE DISTINCT BUT OVERLAPPING REMARK 1 TITL 2 BINDING SPECIFICITIES REMARK 1 REF J.BIOL.CHEM. V. 270 27407 1995 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.M.ZHOU,K.S.RAVICHANDRAN,E.F.OLEJNICZAK,A.M.PETROS, REMARK 1 AUTH 2 R.P.MEADOWS,M.SATTLER,J.E.HARLAN,W.S.WADE,S.J.BURAKOFF, REMARK 1 AUTH 3 S.W.FESIK REMARK 1 TITL STRUCTURE AND LIGAND RECOGNITION OF THE PHOSPHOTYROSINE REMARK 1 TITL 2 BINDING DOMAIN OF SHC REMARK 1 REF NATURE V. 378 584 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.J.O'NEILL,A.CRAPARO,T.A.GUSTAFSON REMARK 1 TITL CHARACTERIZATION OF AN INTERACTION BETWEEN INSULIN RECEPTOR REMARK 1 TITL 2 SUBSTRATE 1 AND THE INSULIN RECEPTOR BY USING THE TWO-HYBRID REMARK 1 TITL 3 SYSTEM REMARK 1 REF MOL.CELL.BIOL. V. 14 6433 1994 REMARK 1 REFN ISSN 0270-7306 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SET OF IDEAL BOND LENGTHS AND ANGLES REMARK 3 USED DURING REFINEMENT: PARALLHDG.PRO IN X-PLOR. REMARK 4 REMARK 4 1IRS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174245. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 158 47.10 -83.94 REMARK 500 LEU A 168 157.63 -45.06 REMARK 500 GLN A 175 -45.21 -150.05 REMARK 500 THR A 188 46.08 -99.16 REMARK 500 SER A 189 28.74 38.61 REMARK 500 LYS A 190 -34.83 169.35 REMARK 500 ASN A 198 37.11 -99.52 REMARK 500 GLU A 200 -54.78 -133.27 REMARK 500 SER A 217 90.35 -64.14 REMARK 500 GLU A 218 -88.53 64.01 REMARK 500 VAL A 240 -163.93 -107.86 REMARK 500 ASP A 242 -146.93 -171.81 REMARK 500 PHE A 264 -70.49 -81.13 REMARK 500 ARG A 265 145.98 171.37 REMARK 500 PRO A 266 -152.33 -55.68 REMARK 500 ARG B 498 -81.78 72.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 184 0.22 SIDE CHAIN REMARK 500 ARG A 212 0.20 SIDE CHAIN REMARK 500 ARG A 213 0.18 SIDE CHAIN REMARK 500 ARG A 227 0.31 SIDE CHAIN REMARK 500 ARG A 258 0.29 SIDE CHAIN REMARK 500 ARG A 265 0.24 SIDE CHAIN REMARK 500 ARG A 267 0.26 SIDE CHAIN REMARK 500 ARG B 498 0.31 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1IRS A 157 267 UNP P35568 IRS1_HUMAN 157 267 DBREF 1IRS B 489 499 UNP P24394 IL4RA_HUMAN 489 499 SEQADV 1IRS PTR B 497 UNP P24394 TYR 497 MODIFIED RESIDUE SEQRES 1 A 112 MET GLY PRO ALA PHE LYS GLU VAL TRP GLN VAL ILE LEU SEQRES 2 A 112 LYS PRO LYS GLY LEU GLY GLN THR LYS ASN LEU ILE GLY SEQRES 3 A 112 ILE TYR ARG LEU CYS LEU THR SER LYS THR ILE SER PHE SEQRES 4 A 112 VAL LYS LEU ASN SER GLU ALA ALA ALA VAL VAL LEU GLN SEQRES 5 A 112 LEU MET ASN ILE ARG ARG CYS GLY HIS SER GLU ASN PHE SEQRES 6 A 112 PHE PHE ILE GLU VAL GLY ARG SER ALA VAL THR GLY PRO SEQRES 7 A 112 GLY GLU PHE TRP MET GLN VAL ASP ASP SER VAL VAL ALA SEQRES 8 A 112 GLN ASN MET HIS GLU THR ILE LEU GLU ALA MET ARG ALA SEQRES 9 A 112 MET SER ASP GLU PHE ARG PRO ARG SEQRES 1 B 11 LEU VAL ILE ALA GLY ASN PRO ALA PTR ARG SER MODRES 1IRS PTR B 497 TYR O-PHOSPHOTYROSINE HET PTR B 497 25 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR C9 H12 N O6 P HELIX 1 1 LEU A 173 THR A 176 1 4 HELIX 2 2 VAL A 245 ASP A 262 1 18 HELIX 3 3 PRO B 495 PTR B 497 5 3 SHEET 1 A 4 GLU A 162 ILE A 167 0 SHEET 2 A 4 ILE A 182 THR A 188 -1 N LEU A 187 O GLU A 162 SHEET 3 A 4 THR A 191 LYS A 196 -1 N VAL A 195 O ARG A 184 SHEET 4 A 4 VAL A 204 GLN A 207 -1 N LEU A 206 O ILE A 192 SHEET 1 B 3 GLY A 234 PHE A 236 0 SHEET 2 B 3 PHE A 220 VAL A 225 -1 N VAL A 225 O GLY A 234 SHEET 3 B 3 ILE A 211 SER A 217 -1 N SER A 217 O PHE A 220 LINK C ALA B 496 N PTR B 497 1555 1555 1.31 LINK C PTR B 497 N ARG B 498 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000